Skip to content
The Tokyo

Health ministry questions reliability of vasculitis drug approval data

Health ministry questions reliability of vasculitis drug approval data
Photo: The Japan Times · view original

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

Sources and story details